At Medivant Healthcare, our core activity is the production of sterile injectable medications, essential in modern medical care. Operating from our fully automated facility in Chandler, Arizona, we focus on manufacturing Single Dose Liquid Injectable vials with a commitment to quality, safety, and adherence to cGMP and FDA standards. Our daily production capabilities, targeting both common and shortage-list medications, play a crucial role in meeting healthcare needs across the United States.
Medivant Healthcare is at the forefront of retina care innovation with our repackaged Avastin ® in prefilled Ompi Alba glass syringes, distinctly surpassing the traditional hand-drawn methods used by other companies. Our state-of-the-art, automated filling process not only ensures unparalleled precision and consistency in dosing but also significantly enhances safety and efficacy. A standout feature of our syringes is the impressive 365-day Beyond-Use Date (BUD), the longest available in the market. This extended BUD underscores the stability and longevity of the medication, ensuring that healthcare providers have access to a product with maximum shelf-life without compromising on quality or effectiveness. By employing high-quality Ompi Alba glass syringes, we further guarantee the integrity and purity of Bevacizumab, providing healthcare professionals and patients with a superior, reliable, and safe therapeutic option.
